Long-Term Results of the Spanish Trial on Treatment and Survival of Patients with Predominantly Mild Heart Failure

345 patients with mild to moderate heart failure (NYHA functional classes 2 and 3) without atrial fibrillation, dyspnea of bronchopulmonary origin, or hypertension not controlled with diuretics

Captopril plus diuretics

Digoxin plus diuretics

Mortality, hospitalization for cardiac events, deterioration in quality of life, worsening of functional class, and need for crossover treatment (digoxin or captopril)hard clinical